| scholarly article | Q13442814 |
| P356 | DOI | 10.2106/00004623-199604000-00005 |
| P698 | PubMed publication ID | 8609130 |
| P2093 | author name string | R Estrada | |
| R B Gustilo | |||
| D T Tsukayama | |||
| P433 | issue | 4 | |
| P304 | page(s) | 512-523 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Journal of Bone and Joint Surgery | Q6294867 |
| P1476 | title | Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections | |
| P478 | volume | 78 |
| Q58100793 | A new perspective on current prosthetic joint infection classifications: introducing topography as a key factor affecting treatment strategy |
| Q37066582 | A superficial swab culture is useful for microbiologic diagnosis in acute prosthetic joint infections. |
| Q33956359 | A two-stage retention débridement protocol for acute periprosthetic joint infections |
| Q38124795 | Acrylic bone cement: current concept review. |
| Q37703145 | Acute Delayed or Late Infection of Revision Total Hip Arthroplasty Treated with Debridement/Antibiotic-loaded Cement Beads and Retention of the Prosthesis |
| Q41954355 | Acute infection in total knee arthroplasty: diagnosis and treatment |
| Q88405928 | Acute periprosthetic knee infection: is there still a role for DAIR? |
| Q35021550 | Adherence ability of Staphylococcus epidermidis on prosthetic biomaterials: an in vitro study |
| Q74613182 | Advances in the diagnosis of infection in prosthetic joint implants |
| Q37570739 | Aggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements |
| Q36293329 | Aggressive early débridement for treatment of acutely infected cemented total hip arthroplasty |
| Q36085748 | Antibacterial and biological characteristics of silver containing and strontium doped plasma sprayed hydroxyapatite coatings. |
| Q35571578 | Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection |
| Q34519245 | Baseline hypovitaminosis D is not associated with poor clinical outcomes in osteoarticular infections |
| Q42704857 | Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model |
| Q42272395 | Bone and joint infections in adults: a comprehensive classification proposal |
| Q37597180 | Bone cement product and failure in total knee arthroplasty |
| Q33782869 | Burden of Surgical Site Infections Associated with Select Spine Operations and Involvement of Staphylococcus aureus |
| Q30385877 | CLINICAL OUTCOME AFTER INFECTED TOTAL KNEE AND TOTAL HIP ARTHROPLASTY |
| Q34622239 | Can Implant Retention be Recommended for Treatment of Infected TKA? |
| Q38230862 | Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention? |
| Q35745818 | Candida infections of medical devices |
| Q46556068 | Cement spacer loaded with antibiotics for infected implants of the hip joint |
| Q99405806 | Cemented prosthesis as spacer for two-stage revision of infected hip prostheses: a similar infection remission rate and a lower complication rate |
| Q42287781 | Characteristics and outcome of 16 periprosthetic shoulder joint infections. |
| Q56115840 | Characteristics of bacterial biofilm associated with implant material in clinical practice |
| Q36141357 | Chronic Periprosthetic Hip Joint Infection. A Retrospective, Observational Study on the Treatment Strategy and Prognosis in 130 Non-Selected Patients |
| Q35885138 | Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis |
| Q37617966 | Classification of hip joint infections |
| Q37147669 | Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and Knee Infection |
| Q43962636 | Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections |
| Q36360233 | Comparison of infection control rates and clinical outcomes in culture-positive and culture-negative infected total-knee arthroplasty |
| Q35104528 | Critical care in orthopedic and spine surgery |
| Q92962537 | DAIR (Debridement, Antibiotics and Implant Retention) less effective in hematogenous total knee arthroplasty infections |
| Q90005169 | Debridement, Antibiotics and Implant Retention for Early Periprosthetic Infections of the Hip: Outcomes and Influencing Factors |
| Q90226337 | Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection |
| Q34100226 | Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study |
| Q42041605 | Diagnosis and management of infected total knee arthroplasty. |
| Q44009193 | Diagnosis and treatment of periprosthetic infections |
| Q41345893 | Diagnosis of periprosthetic hip infections |
| Q37170839 | Diagnosis of periprosthetic joint infection: the threshold for serological markers |
| Q89456028 | Diagnosis of the failed total hip replacement |
| Q36233269 | Does a prefabricated gentamicin-impregnated, load-bearing spacer control periprosthetic hip infection? |
| Q41652904 | Does intraoperative tissue sample enrichment help or hinder the identification of microorganisms in prosthetic joint infection? |
| Q94453543 | Drug-Induced Thrombocytopenia Secondary to Commonly Used Antibiotics in Total Joint Arthroplasty |
| Q92758538 | Early Diagnosis of Periprosthetic Joint Infection of the Hip-Current Status, Advances, and Perspectives |
| Q36013589 | Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years |
| Q34315218 | Early staphylococcal biofilm formation on solid orthopaedic implant materials: in vitro study |
| Q34168350 | Effect of surface roughness of biomaterials on Staphylococcus epidermidis adhesion |
| Q33374803 | Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. |
| Q37147665 | Efficacy of Debridement for Early Periprosthetic Joint Infection after Hip Arthroplasty |
| Q36195162 | Elution and Mechanical Strength of Vancomycin-Loaded Bone Cement: In Vitro Study of the Influence of Brand Combination |
| Q37125354 | Eradication of multidrug-resistant Acinetobacter baumannii in a female patient with total hip arthroplasty, with debridement and retention: a case report |
| Q90913027 | Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy" |
| Q38753703 | Extended trochanteric osteotomy: current concepts review |
| Q36484891 | Failure of irrigation and débridement for early postoperative periprosthetic infection |
| Q89433457 | Histopathological Diagnosis of Prosthetic Joint Infection: Does a Threshold of 23 Neutrophils Do Better than Classification of the Periprosthetic Membrane in a Prospective Multicenter Study? |
| Q36146837 | Immobilized antibiotics to prevent orthopaedic implant infections |
| Q28071834 | Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how? |
| Q36496529 | Improved Diagnosis of Prosthetic Joint Infection by Culturing Periprosthetic Tissue Specimens in Blood Culture Bottles |
| Q88993321 | Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection |
| Q59617491 | Infecciones relacionadas con las prótesis articulares: incidencia, factores de riesgo, características clínicas y pronóstico |
| Q43416889 | Infected knee prostheses. Part 1: early infection or acute hematogenous infection |
| Q43602167 | Infected knee prostheses. Part 2: chronic late infections |
| Q35590535 | Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm |
| Q91867898 | Infection after total knee replacement: diagnosis and treatment |
| Q35242716 | Infection control rate of irrigation and débridement for periprosthetic joint infection |
| Q37810488 | Infection in total hip replacement: meta-analysis |
| Q43910926 | Infections in joint prostheses: epidemiology and clinical presentation. A prospective study 1992-1999 |
| Q38490164 | Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections. |
| Q33295154 | Inhibition of staphylococcal biofilm formation by nitrite |
| Q41372514 | Irrigation and debridement for periprosthetic infections of the hip and factors determining outcome |
| Q33956441 | Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections |
| Q36912965 | Is arthroplasty immediately after an infected case a risk factor for infection? |
| Q38450497 | Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review |
| Q43063538 | Is there still a place for continuous closed irrigation in the management of periprosthetic total knee infection? |
| Q38995472 | Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults |
| Q52660401 | Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors. |
| Q35242744 | Leukocytosis is common after total hip and knee arthroplasty |
| Q42780506 | Liquid antibiotics in bone cement: an effective way to improve the efficiency of antibiotic release in antibiotic loaded bone cement. |
| Q51228336 | Low sensitivity of histology to predict the presence of microorganisms in suspected aseptic loosening of a joint prosthesis. |
| Q27015829 | Management of Periprosthetic Hip Joint Infection |
| Q40733299 | Management of prosthetic joint infections |
| Q35869241 | Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating. |
| Q35910321 | Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin |
| Q41441132 | Microbiological diagnosis of periprosthetic joint infections |
| Q35180941 | Molecular characterization of an early invasive Staphylococcus epidermidis prosthetic joint infection |
| Q36734892 | Multiplex Antibody Detection for Noninvasive Genus-Level Diagnosis of Prosthetic Joint Infection |
| Q92126545 | Normal trajectory of Interleukin-6 and C-reactive protein in the perioperative period of total knee arthroplasty under an enhanced recovery after surgery scenario |
| Q46505412 | Nuclear medical imaging in case of painful knee arthroplasty |
| Q37187474 | One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome |
| Q37570729 | One-stage Exchange Arthroplasty for Periprosthetic Hip and Knee Joint Infections |
| Q37581877 | Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection. |
| Q44430511 | Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999 |
| Q35141244 | Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus |
| Q58571777 | Outcome of Irrigation and Debridement after Failed Two-Stage Reimplantation for Periprosthetic Joint Infection |
| Q37170879 | Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection |
| Q84961317 | Outcomes of revision total hip replacement for infection after grading according to a standard protocol |
| Q41591853 | PCR diagnostic system in the treatment of prosthetic joint infections. |
| Q37472391 | Partial two-stage exchange for infected total hip arthroplasty: a preliminary report |
| Q33787241 | Pathophysiology of surgical site infection in total hip arthroplasty |
| Q38190871 | Performance characteristics of broth-only cultures after revision total joint arthroplasty |
| Q61818495 | Periprosthetic Joint Infection |
| Q49848562 | Periprosthetic Joint Infection of Shoulder Arthroplasties: Diagnostic and Treatment Options. |
| Q89536316 | Periprosthetic hip infection treated with two-stage stage-one Select Spacer- complication rate and restoration of anatomy |
| Q41393186 | Periprosthetic infections of the hip joint : Clinical approach |
| Q36424080 | Periprosthetic joint infections at a teaching hospital in 1990-2007. |
| Q37402408 | Periprosthetic knee infection: ten strategies that work |
| Q54326220 | Periprosthetic knee infection: two stage revision surgery. |
| Q37392879 | Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis |
| Q36657727 | Polymicrobial prosthetic joint infections: risk factors and outcome |
| Q33838697 | Positive culture rate in revision shoulder arthroplasty |
| Q36803880 | Preoperative waiting time increased the risk of periprosthetic infection in patients with femoral neck fracture |
| Q35745850 | Prevention of Periprosthetic Joint Infection. |
| Q33678576 | Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group |
| Q88779847 | Prosthetic Joint Infections: an Update |
| Q87601050 | Prosthetic joint infection |
| Q36363093 | Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication |
| Q38921601 | Prosthetic joint infection-a devastating complication of hemiarthroplasty for hip fracture |
| Q89629553 | Prosthetic joint infections: diagnosis, management, and complications of the two-stage replacement arthroplasty |
| Q37158397 | Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients |
| Q79881881 | Purulent bloody drainage after infected total hip arthroplasty: a sign of a leaking mycotic aneurysm |
| Q34207733 | Radiological features do not predict failure of two-stage arthroplasty for prosthetic joint infection: a retrospective case-control study |
| Q34656757 | Reduced re-infection rates with postoperative oral antibiotics after two-stage revision hip arthroplasty |
| Q50103437 | Removal of infected canine cemented total hip prostheses using a femoral window technique |
| Q44307317 | Replacement of infected knee and hip endoprostheses |
| Q37025833 | Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty |
| Q35851188 | Retention treatment after periprosthetic total hip arthroplasty infection |
| Q50014372 | Risk factors for early infection following hemiarthroplasty in elderly patients with a femoral neck fracture. |
| Q34153015 | Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study |
| Q38480446 | Risk factors for treatment failure in patients with prosthetic joint infections |
| Q54326223 | Rivaroxaban and early periprostethic joint infection: our experience. |
| Q93221067 | Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections |
| Q54333163 | Routine one-stage exchange for chronic infection after total hip replacement. |
| Q35540688 | Sepsis Confirmed: What Do You Do Now? |
| Q59261439 | Situación funcional de los pacientes tras resección de artroplastia de cadera (Girdlestone) |
| Q46823383 | Soft tissue healing in infected arthroplasty |
| Q42107494 | Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro |
| Q89028630 | Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections |
| Q40323388 | Specific Infectious Organisms Associated With Poor Outcomes in Treatment for Hip Periprosthetic Infection |
| Q37213206 | Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? |
| Q34478074 | Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. |
| Q58789832 | Success Rate of Fungal Peri-Prosthetic Joint Infection Treated by 2-Stage Revision and Potential Risk Factors of Treatment Failure: A Retrospective Study |
| Q33596975 | Successful treatment of late Salmonella infections in total hip replacement - report of two cases |
| Q37151234 | Surgical site infections in older adults: epidemiology and management strategies |
| Q35143871 | Suture-related pseudoinfection after total hip arthroplasty |
| Q34547886 | Systematic review and meta-analysis of antibiotic therapy for bone and joint infections |
| Q33704621 | The Clinical Usefulness of (99m)Tc HMPAO Leukocyte/(99m)Tc Phytate Bone Marrow Scintigraphy for Diagnosis of Prosthetic Knee Infection: A Preliminary Study |
| Q91998969 | The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms |
| Q47597079 | The Kidney, Liver, Index surgery and C reactive protein score is a predictor of treatment response in acute prosthetic joint infection. |
| Q91761876 | The Right Time to Safely Re-Evaluate Empirical Antimicrobial Treatment of Hip or Knee Prosthetic Joint Infections |
| Q89850156 | The Use of Antibiotic Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements |
| Q41053214 | The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections |
| Q81138666 | The role of intraoperative cultures at the time of reimplantation in the management of infected total joint arthroplasty |
| Q42277352 | The routine use of atypical cultures in presumed aseptic revisions is unnecessary |
| Q36649685 | Tibial tubercle osteotomy or quadriceps snip in two-stage revision for prosthetic knee infection? A randomized prospective study |
| Q39655049 | Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection |
| Q34848097 | Treatment Options for Orthopedic Device-related Infections |
| Q27022797 | Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts |
| Q38975821 | Treatment of early postoperative infections after THA: a decision analysis |
| Q40363780 | Treatment of infected hip arthroplasty |
| Q37084442 | Treatment of prosthetic joint infections due to Propionibacterium. Similar results in 60 patients treated with and without rifampicin |
| Q34072178 | Two stage hip revision in periprosthetic infection: results of 41 cases |
| Q35598885 | Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years |
| Q36360166 | Two-stage arthroplasty using functional temporary prosthesis to treat infected arthroplasty and septic arthritis of the hip. |
| Q58760021 | Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis |
| Q36545795 | Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality |
| Q40310322 | Usefulness of Urinoculture to Patients With Dementia and Femoral Neck Fracture at Admission to Hospital: Preliminary Results. |
| Q61767091 | Valor de la gammagrafía de médula macrofágica en el diagnóstico de infección de prótesis total de cadera estudiada con leucocitos 99mTc-HMPAO |
| Q54095666 | Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. |
| Q36106178 | Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study |
| Q44401835 | Wear particles: key to aseptic prosthetic loosening? |
| Q34283646 | What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? |
| Q33989871 | What is the significance of a positive Propionibacterium acnes culture around a joint replacement? |
| Q37072292 | What is the success of treatment of hip and knee candidal periprosthetic joint infection? |
| Q31102333 | Wound complications in elective orthopaedics: are current British national data relevant? |
| Q84183068 | [Antibiotic prophylaxis in primary and revision hip arthroplasty: what is the evidence?] |
| Q79776248 | [Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations] |
| Q84600789 | [Infection in Joint Prosthesis. When Should it Be Suspected?] |
| Q74353864 | [Infections on joint prostheses] |
| Q79876166 | [Literature and own strategies concerning soft-tissue reconstruction and exposed osteosynthetic hardware] |
| Q82864113 | [Medium-term results of surgical treatment for osteitis of the clavicle] |
| Q80314062 | [Osteitis. Infections of the locomotive system] |
| Q80095580 | [Osteomyelitis after endoprostheses] |
| Q90582009 | [Revision surgery in acute periprosthetic knee joint infections] |
| Q84380265 | [Risk factors for failed cleansing following periprosthetic delayed hip prosthesis infection] |
| Q80051006 | [Surveillance of operative site infections in an orthopedic and traumatology surgery department: an example of methodology] |
| Q79553815 | [The treatment of periprosthetic infections] |
| Q79955332 | [Two-stage procedure to exchange septic total hip arthroplasties with late periprosthetic infection. Early results after implantation of a reverse modular hybrid endoprosthesis] |
Search more.